Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report

2026-02-25 - 13:13

As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.